文献速递心力衰竭与心肌病心律失常

腕管综合征与淀粉样变性、心力衰竭及不良心血管结局的关联

Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

基于丹麦全国登记数据,1996至2012年间56,032例接受腕管综合征手术的患者与性别年龄匹配的普通人群对照(1:1)比较,评估其淀粉样变性、心力衰竭及其他不良心血管结局风险。结果显示腕管综合征与淀粉样变性(HR 12.12)及心力衰竭(校正HR 1.54)风险升高相关,其他心血管结局风险亦增加。

要点

  • 腕管综合征手术患者未来淀粉样变性诊断风险显著升高(HR 12.12)。
  • 腕管综合征与心力衰竭风险升高相关,校正后HR为1.54。
  • 房颤、房室传导阻滞及起搏器植入等不良结局风险亦与腕管综合征相关。

核心结论

  • 接受腕管综合征手术的患者相较匹配的普通人群对照,淀粉样变性和心力衰竭风险更高,其他心血管结局风险亦增加。

研究设计与样本

  • 基于丹麦全国登记数据,1996至2012年间识别56,032例接受腕管综合征手术治疗的患者,并与性别和年龄匹配(1:1)的普通人群对照比较。
  • 采用累积发病率曲线和Cox比例风险模型评估组间差异。

主要发现

  • 腕管综合征与未来淀粉样变性诊断相关,风险比12.12(95%CI 4.37至33.60)。
  • 腕管综合征与心力衰竭发病率升高相关,校正分析风险比1.54(95%CI 1.45至1.64)。
  • 未发现与性别的显著交互作用(p=0.5)。
  • 其他不良结局风险亦与腕管综合征相关(房颤、房室传导阻滞和起搏器植入,p<0.0001)。

临床怎么用

  • 对接受腕管综合征手术的患者,临床应关注淀粉样变性及心力衰竭的筛查与评估。
  • 腕管综合征患者的心血管结局风险升高,提示需加强相关心血管疾病的监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies have suggested that transthyretin amyloidosis (ATTR) is a more common cause of heart failure (HF) than previously appreciated, and novel treatments for amyloidosis are emerging. About one-half of patients with ATTR cardiac amyloidosis have a history of carpal tunnel syndrome (CTS). OBJECTIVES: This study examined the risk of amyloidosis, HF, and other adverse cardiovascular outcomes associated with CTS relative to control subjects without CTS. METHODS: Using Danish nationwide registries from 1996 to 2012, 56,032 patients were identified who underwent surgical treatment for CTS, and they were compared with a sex- and age-matched cohort (ratio 1:1) from the general population to examine their risk of amyloidosis, HF, and other adverse cardiovascular outcomes. Cumulative incidence curves and Cox proportional hazard models were used to assess differences. RESULTS: As expected, CTS was associated with a future diagnosis of amyloidosis (hazard ratio: 12.12 [95% confidence interval: 4.37 to 33.60]). CTS was associated with a higher incidence of HF, and this held true in the adjusted analysis yielding a hazard ratio of 1.54 (95% confidence interval: 1.45 to 1.64). No significant interaction with sex was found (p = 0.5). Risk of other adverse outcomes was also associated with CTS (p < 0.0001 for atrial fibrillation, atrioventricular heart block, and pacemaker implantation). CONCLUSIONS: Patients who undergo surgical treatment for CTS are associated with a higher risk of amyloidosis and HF relative to matched control subjects from the general population. Other cardiovascular outcomes were also increased with CTS.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Fosbøl EL, Rørth R, Leicht BP, et al. Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes. J Am Coll Cardiol. 2019. PMID: 31272537. doi:10.1016/j.jacc.2019.04.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。